Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term TS-071 combination therapy with oral antidiabetic agents in type 2 diabetes mellitus
jRCT2080221469
- Sponsor
- Taisho Pharmaceutical
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of luseogliflozin in type 2 diabetes mellitus (T2DM), sponsored by Taisho Pharmaceutical.
02
Drugs
luseogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221469.